SOURCE: Mannatech, Inc.

July 29, 2005 17:30 ET

Mannatech Receives US Ambrotose® Patent Issue Notification

COPPELL, TX -- (MARKET WIRE) -- July 29, 2005 -- Mannatech, Incorporated (NASDAQ: MTEX) announced today that it has received notice from outside patent counsel that a patent issue notification has been mailed by the United States Patent and Trademark Office for its proprietary Ambrotose® complex. Issuance is expected within the next few weeks. The U.S. patent on Ambrotose® will join Mannatech's growing international patent portfolio, which currently includes 18 countries that have issued a patent related to Ambrotose® complex. Sam Caster, Mannatech's Founder, Chairman and CEO, stated, "The science of sugars is one of the most exciting in health and wellness today. This patent will strengthen our position in the explosive wellness market."

"It's been a lot of work, but things of great value are worth waiting for," commented Dr. Bill McAnalley, researcher and lead inventor of the Ambrotose® complex. "In granting this patent, the U.S. Patent and Trademark Office has confirmed that Ambrotose® complex is novel and useful, and Mannatech's sales growth reflects the product's value. I'm so grateful for the opportunity God has given me to help make a difference in the lives of so many people."

"Of all the advancements I've seen in my 42 years as a practicing medical physician, the development of the glyconutrient technology gives me greater cause for hope than anything I've witnessed so far," says Dr. Reginald H. McDaniel, co-inventor of Ambrotose® complex and currently Medical Director of MannaRelief Ministries. "I am honored and humbled to be part of this historic development."

Ambrotose® complex is Mannatech's proprietary brand name for a family of dietary supplements that support the body's immune system to help achieve and maintain optimal health and wellness. Among these products are Advanced Ambrotose™, Ambrotose AO® and original Ambrotose® complex.

In addition to the United States, the company now holds registered patents on its Ambrotose® complex in Australia, France, Germany, Hong Kong, Ireland, Italy, Liechtenstein, Malaysia, Mexico, New Zealand, the Philippines, Singapore, South Africa, South Korea, Spain, Switzerland, Taiwan and the United Kingdom.

About Mannatech, Incorporated

Mannatech, based in Coppell, Texas, is a wellness solutions provider that sells its products through a global network-marketing system throughout the United States and the international markets of Canada, Australia, the United Kingdom, Japan, New Zealand, South Korea and Taiwan, and beginning August 2005 in Denmark. For additional information about Mannatech, please visit its corporate Web site: www.mannatech.com.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified generally by the use of phrases or terminology such as "may," "believes," and "plans" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that its expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions its readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Contact Information

  • Mannatech Media Contact:
    Kevin Young
    972.471.7397
    Email Contact

    Investor Relations Contact:
    Steve Fenstermacher
    972.471.6512
    Email Contact